Title

Enriching for Tumor-Reactive CD8 TIL with CD39/103 Markers: Implications for TIL Therapy

Authors

Andrew D. Weinberg, Earle A. Chiles Research Institute, Providence Cancer InstituteFollow

Document Type

Article

Publication Date

10-20-2021

Publication Title

TIL Therapies Summit

Keywords

oregon; portland; chiles

Clinical Institute

Cancer

Department

Earle A. Chiles Research Institute

Department

Oncology

Recommended Citation

Weinberg, Andrew D., "Enriching for Tumor-Reactive CD8 TIL with CD39/103 Markers: Implications for TIL Therapy" (2021). Articles, Abstracts, and Reports. 5625.
https://digitalcommons.providence.org/publications/5625